More than 4 months have passed since the Fifth Circuit heard oral arguments in my case on December 3, 2025.
While I respect the Court’s deliberative process, the prolonged delay in issuing a decision is concerning—not only for me as the whistleblower who stepped forward at great personal cost, but for the people whose trust in our public health institutions and pharmaceutical oversight hangs in the balance.
I came forward in 2020 after witnessing serious protocol violations, data integrity issues, and safety concerns during Pfizer’s COVID-19 vaccine clinical trial. I reported these problems to the FDA and was terminated the same day.
What I observed raised fundamental questions about the integrity of the process that led to widespread government authorization and procurement of the product—issues that go to the heart of the False Claims Act’s purpose: protecting taxpayer dollars & public safety from fraud.
This is not just my case. It is about accountability in the most significant public health efforts in history. The public deserves transparency and timely justice.
Other cases argued in the same period or shortly after have received decisions, yet this one—carrying profound implications for clinical trial standards, government contracting, conspiracies, coverups and whistleblower protections remains unresolved.
I urge the Fifth Circuit to issue its opinion without further delay.
The evidence presented and the arguments heard deserve a clear ruling so that critical questions about fraud, government knowledge, and corporate responsibility can be addressed.
I remain committed to pursuing this fight (and others) for as long as necessary, on behalf of every patient, taxpayer, and future participant in clinical trials who expects & deserves honesty and rigor in the development of medical products.
B-